Document is current
Any future updates will be listed below
-
Authors
Kouyos, Roger D.
Rusert, Peter
Kadelka, Claus
Huber, Michael
Marzel, Alex
Ebner, Hanna
Schanz, Merle
Liechti, Thomas
Friedrich, Nikolas
Braun, Dominique L.
Scherrer, Alexandra U.
Weber, Jacqueline
Uhr, Therese
Baumann, Nicolas S.
Leemann, Christine
Kuster, Herbert
Chave, Jean-Philippe
Cavassini, Matthias
Bernasconi, Enos
Hoffmann, Matthias
Calmy, Alexandra
Battegay, Manuel
Rauch, Andri
Yerly, Sabine
Aubert, Vincent
Klimkait, Thomas
Böni, Jürg
Metzner, Karin J.
Günthard, Huldrych F.
Trkola, Alexandra
,
Anagnostopoulos, Alexia
Battegay, Manuel
Bernasconi, Enos
Böni, Jürg
Braun, Dominique L.
Bucher, Heiner C.
Calmy, Alexandra
Cavassini, Matthias
Ciuffi, Angela
Dollenmaier, Günter
Egger, Matthias
Elzi, Luigia
Fehr, Jan
Fellay, Jacques
Furrer, Hansjakob
Fux, Christoph A.
Günthard, Huldrych F.
Haerry, David
Hasse, Barbara
Hirsch, Hans H.
Hoffmann, Matthias
Hösli, Irene
Huber, Michael
Kahlert, Christian
Kaiser, Laurent
Keiser, Olivia
Klimkait, Thomas
Kouyos, Roger D.
Kovari, Helen
Ledergerber, Bruno
Martinetti, Gladys
Martinez de Tejada, Begona
Marzolini, Catia
Metzner, Karin J.
Müller, Nicolas
Nicca, Dunja
Paioni, Paolo
Pantaleo, Guiseppe
Perreau, Matthieu
Rauch, Andri
Rudin, Christoph
Scherrer, Alexandra U.
Schmid, Patrick
Speck, Roberto
Stöckle, Marcel
Tarr, Philip
Trkola, Alexandra
Vernazza, Pietro
Wandeler, Gilles
Weber, Rainer
Yerly, Sabine
- License Information
-
More Information
Article History
Received: 12 February 2018
Accepted: 9 August 2018
First Online: 10 September 2018
Competing interests
: The University of Zurich filed a European patent application (EP18184854.0) that includes the full envelope sequences of patients T282 and R282 or components thereof for use as bNAb-inducing immunogens with R.D.K., P.R., H.F.G. and A.T. listed as inventors. All other authors declare no competing interests.
